看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | No |
| Is net profit margin increasing? | Yes | No |
| Is asset turnover increasing? | Yes | Yes |
| Is equity multiplier increasing? | Yes | No |
| Competitors Used |
|---|
| GSK plc |
| Sanofi |
| Bayer Aktiengesellschaft |
| Pfizer Inc. |
| Perrigo Company plc |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| GSK1 N | SAN1 N | BAYN N | PFE * | PRGO N | GEKA | |||
| Return On Equity | ||||||||
| Latest Twelve Months | 23% | NA | -8% | 9% | -4% | 20% | ||
| Fiscal Year - 1 | 41% | 7% | -8% | 2% | 0% | 11% | ||
| Fiscal Year - 2 | 35% | 11% | 12% | 36% | -3% | 14% | ||
| Fiscal Year - 3 | 22% | 9% | 3% | 32% | -2% | 14% | ||
| Fiscal Year - 4 | 37% | 20% | -40% | 10% | 1% | 17% | ||
| Fiscal Year - 5 | 61% | 5% | 5% | 17% | 3% | 10% | ||
| Average | 37% | 10% | -6% | 18% | -1% | 14% | ||
| Median | 36% | 9% | -2% | 14% | -1% | 14% | ||
| Benchmarks | Ticker | |||||||
| GSK plc | BMV:GSK1N | |||||||
| Sanofi | BMV:SAN1N | |||||||
| Bayer Aktiengesellschaft | BMV:BAYNN | |||||||
| Pfizer Inc. | BMV:PFE* | |||||||
| Perrigo Company plc | BMV:PRGON | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | GSK1 N | SAN1 N | BAYN N | PFE * | PRGO N | GEKA | ||
| Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| LTM Period | Mar-25 | Mar-25 | Dec-24 | Mar-25 | Dec-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 31,529 | 45,166 | 46,606 | 62,464 | 4,373 | 18,607 | ||
| Fiscal Year | 31,376 | 44,286 | 46,606 | 63,627 | 4,373 | 18,607 | ||
| Fiscal Year - 1 | 30,328 | 41,109 | 47,637 | 59,554 | 4,656 | 16,467 | ||
| Fiscal Year - 2 | 29,324 | 40,304 | 50,739 | 101,175 | 4,452 | 16,820 | ||
| Fiscal Year - 3 | 24,696 | 39,175 | 44,081 | 81,288 | 4,139 | 15,487 | ||
| Fiscal Year - 4 | 24,354 | 37,369 | 41,400 | 41,651 | 4,088 | 13,870 | ||
| Fiscal Year - 5 | 33,754 | 37,631 | 43,545 | 40,905 | 3,870 | 12,713 | ||
| Net Income | ||||||||
| Latest Twelve Months | 3,153 | 6,218 | (2,552) | 7,867 | (161) | 2,137 | ||
| Fiscal Year | 2,575 | 5,496 | (2,552) | 8,020 | (161) | 2,137 | ||
| Fiscal Year - 1 | 4,928 | 5,062 | (2,941) | 2,134 | (4) | 1,085 | ||
| Fiscal Year - 2 | 4,461 | 7,970 | 4,150 | 31,366 | (131) | 1,389 | ||
| Fiscal Year - 3 | 3,316 | 6,223 | 1,000 | 22,413 | (131) | 1,308 | ||
| Fiscal Year - 4 | 4,873 | 12,294 | (15,569) | 6,630 | 44 | 1,404 | ||
| Fiscal Year - 5 | 4,645 | 2,855 | 2,391 | 10,707 | 159 | 750 | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 58,511 | NA | 116,259 | 221,095 | 10,809 | 20,738 | ||
| Latest Fiscal Quarter | 60,705 | NA | 110,850 | NA | 9,648 | 24,083 | ||
| Fiscal Year | 59,463 | 132,798 | 110,850 | 213,396 | 9,648 | 24,083 | ||
| Fiscal Year - 1 | 59,005 | 126,464 | 116,259 | 226,501 | 10,809 | 20,738 | ||
| Fiscal Year - 2 | 60,146 | 126,722 | 124,877 | 197,205 | 11,017 | 21,607 | ||
| Fiscal Year - 3 | 79,103 | 120,242 | 120,241 | 181,476 | 10,426 | 21,543 | ||
| Fiscal Year - 4 | 80,431 | 114,413 | 116,804 | 154,229 | 11,488 | 21,341 | ||
| Fiscal Year - 5 | 79,692 | 112,630 | 126,174 | 167,594 | 11,301 | 18,530 | ||
| Fiscal Year - 6 | 58,066 | 111,408 | 126,732 | 159,422 | 10,983 | 18,077 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 13,840 | 74,040 | 32,927 | 92,282 | 4,768 | 9,441 | ||
| Latest Fiscal Quarter | 14,157 | 77,507 | 31,908 | 88,203 | 4,319 | 11,589 | ||
| Fiscal Year | 13,671 | 77,507 | 31,908 | 88,203 | 4,319 | 11,589 | ||
| Fiscal Year - 1 | 13,347 | 74,040 | 32,927 | 89,014 | 4,768 | 9,441 | ||
| Fiscal Year - 2 | 10,598 | 74,784 | 38,773 | 95,661 | 4,842 | 10,153 | ||
| Fiscal Year - 3 | 15,055 | 68,681 | 33,020 | 77,201 | 5,152 | 10,072 | ||
| Fiscal Year - 4 | 14,587 | 63,106 | 30,523 | 63,238 | 5,655 | 8,842 | ||
| Fiscal Year - 5 | 11,405 | 59,056 | 47,253 | 63,126 | 5,804 | 7,249 | ||
| Fiscal Year - 6 | 3,781 | 58,876 | 45,977 | 63,388 | 5,668 | 7,428 | ||